| Dedicated to Clinical & Academic Exchange of Information |

Protocol Development Committee (PDC)
Thank you to all of you who attended the recent Protocol Development Committee Meeting in Chicago. Minutes from the meeting and several of the powerpoint prestations will soon be posted in the Members Only portion of the website on the PDC Meeting Minutes dropdown.
European Protocol Development Committee (EPDC)
The CyberKnife Society (CKS) is holding its first European Protocol Development Committee (EPDC) meeting on Saturday, October 10, 2009 in Milan, Italy. Dr. Alexander Muacevic, from European CyberKnife Zentrum München in Germany will be chairing the EPDC.
There is no registration fee for this meeting, however travel and hotel expenses are the responsibility of each attendee. Eligibility to attend the EPDC requires attendees be an active CyberKnife Society (CKS) member. If you're not a CKS member, you can sign up by clicking the Become A Member link in the upper right of this page.
Details on the EPDC agenda, meeting registration and hotel accommodations will be forthcoming.
For further questions and assistance, please contact Nalani Brown nbrown@cksociety.org.
ATTENTION
CyberKnife Patients with Cancers of the Prostate and Other Soft Tissues
Please click here to be redirect to a very important message regarding changes in coverage.
Claim Your CME/CE Credits
About the Society
The CyberKnife® Society (CKS) was initially organized in 2002 by Dr. John Adler under the auspices of Accuray® Incorporated (Publicly traded under NASDAQ). After 5 years and over 500 members, on January 14, 2008, The CyberKnife Society officially formed as a non-profit (501c6). Accuray Incorporated continues to be a generous financial sponsor that along with our membership dues supports The CKS to continue our vision as defined below:
We believe we are limited only by our imagination in our efforts to painlessly destroy cancer and other disorders throughout the body - throughout the world. The CyberKnife Society is dedicated to realizing this dream.